Hong Kong and China review AI for cancer pathology diagnostics

mobihealthnews.com

An AI pathology system for cancer diagnostics is seeking regulatory approval in Hong Kong and mainland China. Trained on over 500,000 slides, the AI predicts cancer type, treatment response, and survival with over 95% accuracy in minutes. The SmartPath system automates pathology workflows, aiming to speed up diagnostics and support personalized cancer treatment planning.


With a significance score of 4, this news ranks in the top 5.2% of today's 33411 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Hong Kong and China review AI for cancer pathology diagnostics | News Minimalist